Insights: Publications Navigating Key Differences in Therapeutic Antibody Patent Protection Strategies Between the United States and Europe

Kilpatrick Townsend MEMO|Biopharma Industry Blog

Written by Yifan Mao
Many of today’s top-selling drugs worldwide are therapeutic antibodies thus antibody-related inventions can be extremely valuable. Developing antibody therapeutics requires significant resources and time, so it is paramount to develop a robust patent strategy to protect that investment, prevent reverse-engineering, and minimize design-arounds.

Related People

close
Loading...
If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”